Management of long-term and reversible hysteroscopic sterilization: a novel device with nickel-titanium shape memory alloy

Reproductive Biology and Endocrinology

Aixingzi Aili²  Dabao Xu¹  Ke-an Zhu¹  Bin Xu¹ 

[1] Department of Gynecology, Third Xiangya Hospital of Central South University, 138 Tongzipo Rd, Changsha City, Hunan Province 410013, China;Department of Gynecology, Shanghai East Hospital of Tongji University, 150 Jimo Rd, Shanghai 200120, China

关键词: In vitro fertilization;    Reversibility;    Contraception;    Hysteroscopic sterilization;    Shape memory;    Nickel-titanium alloy;   

Others  :  1149544
DOI  :  10.1186/1477-7827-12-61

 received in 2014-04-12, accepted in 2014-07-01,  发布年份 2014

【 摘 要 】

Background

Female sterilization is the second most commonly used method of contraception in the United States. Female sterilization can now be performed through laparoscopic, abdominal, or hysteroscopic approaches. The hysteroscopic sterilization may be a safer option than sterilization through laparoscopy or laparotomy because it avoids invading the abdominal cavity and undergoing general anaesthesia. Hysteroscopic sterilization mainly includes chemical agents and mechanical devices. Common issues related to the toxicity of the chemical agents used have raised concerns regarding this kind of contraception. The difficulty of the transcervical insertion of such mechanical devices into the fallopian tubes has increased the high incidence of device displacement or dislodgment. At present, Essure^® is the only commercially available hysteroscopic sterilization device being used clinically. The system is irreversible and is not effective immediately.

Presentation of the hypothesis

Our new hysteroscopic sterility system consists of nickel-titanium (NiTi) shape memory alloy and a waterproof membrane. The NiTi alloy is covered with two coatings to avoid toxic Ni release and to prevent stimulation of epithelial tissue growth around the oviducts. Because of the shape memory effect of the NiTi alloy, the device works like an umbrella: it stays collapsed at low temperature before placement and opens by the force of shape memory activated by the body temperature after it is inserted hysteroscopically into the interstitial tubal lumen. The rim of the open device will incise into interstitial myometrium during the process of unfolding. Once the device is fixed, it blocks the tube completely. When the patient no longer wishes for sterilization, the device can be closed by perfusing liquid with low temperature into the uterine cavity, followed by prospective hysteroscopic removal. After the device removal, the fallopian tube will revert to its physiological functions.

Testing the hypothesis

Currently, experimental and clinical studies are needed to attest the safety, efficiency and reversibility of the novel sterilization device.

Implications of the hypothesis

If our hypothesis is confirmed, appropriate and reversible contraceptive can be achieved with the device we have designed, which may have significant repercussions for numerous women worldwide.

【 授权许可】

   
2014 Xu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Castaño PM, Adekunle L: Transcervical sterilization. Semin Reprod Med 2010, 28:103-109.
• [2]Abbott J: Transcervical sterilization. Curr Opin Obstet Gynecol 2007, 19:325-330.
• [3]Smith RD: Contemporary hysteroscopic methods for female sterilization. Int J Gynaecol Obstet 2010, 108:79-84.
• [4]Kraemer DF, Yen PY, Nichols M: An economic comparison of female sterilization of hysteroscopic tubal occlusion with laparoscopic bilateral tubal ligation. Contraception 2009, 80:254-260.
• [5]Maubon AJ, Thurmond AS, Laurent A, Honiger JE, Scanlan RM, Rouanet JP: Selective tubal sterilization in rabbits: experience with a hydrogel combined with a sclerosing agent. Radiology 1994, 193:721-723.
• [6]Bigolin S, Fagundes DJ, Rivoire HC, Fagundes AT, Fagundes AL: Transcervical hysteroscopic sterilization using cyanoacrylate: a long-term experimental study on sheep. J Obstet Gynaecol Res 2009, 35:1012-1018.
• [7]Bigolin S, Fagundes DJ, Rivoire HC, Fagundes AT, Simões R, Simões Mde J: Hysteroscopic sterilization with occlusion of sheep uterine tube using n-butyl-2-cyanoacrylate adhesive. Acta CirBras 2007, 22:401-406.
• [8]Jensen JT, Rodriguez MI, Liechtenstein-Zábrák J, Zalanyi S: Transcervical polidocanol as a nonsurgical method of female sterilization: a pilot study. Contraception 2004, 70:111-115.
• [9]McLemore R, Kim EJ, Brandon TA, Aerni G, Roy KH, Vernon BL: Tubal sterilization with a waterborne polyethylene glycol in situ cross-linking material: a minimally invasive approach. Fertil Steril 2005, 83(Suppl 1):1284-1292.
• [10]Rehan M, Coleman J, Olabi AG: Novel implant for transcervical sterilization. J Biosci Bioeng 2010, 110:242-249.
• [11]Binkert CA, Pavcnik D, Andrews RT, Loriaux MM, Uchida B, Brountzos EN, Rösch J: Fallopian tube occlusion with use of a small intestine submucosa device: evaluation in a rabbit model. J Vasc Interv Radiol 2004, 15:609-613.
• [12]Tang S, Zhang CY, Huang MN, Luo YF, Liang ZQ: Fallopian tube occlusion with a shape memory polymer device: evaluation in a rabbit model. Contraception 2013, 87:235-241.
• [13]Lendlein A, Langer R: Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science 2002, 296:1673-1676.
• [14]Tarniţă D, Tarniţă DN, Bîzdoacă N, Mîndrilă I, Vasilescu M: Properties and medical applications of shape memory alloys. Rom J Morphol Embryol 2009, 50:15-21.
• [15]Yeung KW, Poon RW, Chu PK, Chung CY, Liu XY, Lu WW, Chan D, Chan SC, Luk KD, Cheung KM: Surface mechanical properties, corrosion resistance, and cytocompatibility of nitrogen plasma-implanted nickel-titanium alloys: a comparative study with commonly used medical grade materials. J Biomed Mater Res A 2007, 82:403-414.
• [16]Ozeki K, Yuhta T, Aoki H, Fukui Y: Inhibition of Ni release from NiTi alloy by hydroxyapatite, alumina, and titanium sputtered coatings. Biomed Mater Eng 2003, 13:271-279.
• [17]Wang LG, Qiu Y, Fan YJ, Li XY, Han XJ: Reversible contraceptive effect of the oviduct plug with nickel-titanium shape memory alloy and silicone rubber in rabbits. Contraception 2011, 83:373-377.
• [18]Ubeda A, Labastida R, Dexeus S: Essure: a new device for hysteroscopic tubal sterilization in an outpatient setting. Fertil Steril 2004, 82:196-199.
• [19]Cleary TP, Tepper NK, Cwiak C, Whiteman MK, Jamieson DJ, Marchbanks PA, Curtis KM: Pregnancies after hysteroscopic sterilization: a systematic review. Contraception 2013, 87:539-548.
• [20]Basinski CM: A review of clinical data for currently approved hysteroscopic sterilization procedures. Rev Obstet Gynecol 2010, 3:101-110.
• [21]Wittmer MH, Famuyide AO, Creedon DJ, Hartman RP: Hysterosalpingography for assessing efficacy of Essure microinsert permanent birth control device. AJR Am J Roentgenol 2006, 187:955-958.
• [22]Hillis SD, Marchbanks PA, Tylor LR, Peterson HB: Poststerilization regret: findings from the United States Collaborative Review of Sterilization. Obstet Gynecol 1999, 93(6):889-895.
• [23]Curtis KM, Mohllajee AP, Peterson HB: Regret following female sterilization at a young age: a systematic review. Contraception 2006, 73:205-210.
• [24]Aliuos P, Sen A, Reich U, Dempwolf W, Warnecke A, Hadler C, Lenarz T, Menzel H, Reuter G: Inhibition of fibroblast adhesion by covalently immobilized protein repellent polymer coatings studied by single cell force spectroscopy. J Biomed Mater Res A 2013, 102:117-127.
• [25]Pena J, Solano E, Mendoza A, Casals J, Planell JA, Gil FJ: Effect of the M(s) transformation temperature on the wear behaviour of NiTi shape memory alloys for articular prosthesis. Biomed Mater Eng 2005, 15:289-293.
• [26]State Intellectual Property Office of the People's Republic of China http://www.pss-system.gov.cn/sipopublicsearch/ensearch/searchEnHomeIndexAC.do webcite
• [27]Sitruk-Ware R, Nath A, Mishell DR Jr: Contraception technology: past, present and future. Contraception 2013, 87:319-330.
• [28]Sitruk-Ware R: Contraception: an international perspective. Contraception 2006, 73:215-222.
• [29]Valle RF, Carignan CS, Wright TC, STOP Prehysterectomy Investigation Group: Tissue response to the STOP microcoil transcervical permanent contraceptive device: results from a prehysterectomy study. Fertil Steril 2001, 76:974-980.
• [30]Palmer SN, Greenberg JA: Transcervical sterilization: a comparison of essure(r) permanent birth control system and adiana(r) permanent contraception system. Rev Obstet Gynecol 2009, 2:84-92.
• [31]Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PG: Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 2010, 93:1338-1342.
• [32]Kerin JF, Cattanach S: Successful pregnancy outcome with the use of in vitro fertilization after Essure hysteroscopic sterilization. Fertil Steril 2007, 87:1212. e1-1212.e4